SCO CAPITAL PARTNERS LLC's Net Worth

-$33.9 Million

Estimate Recalculated Jul 22, 2024 03:32PM EST

Who is SCO CAPITAL PARTNERS LLC?

SCO CAPITAL PARTNERS LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ABEONA THERAPEUTICS INC., ENHANCE BIOTECH INC, Somanta Pharmaceuticals Inc., MACROCHEM CORP, and BIOENVISION INC.

SEC CIK

SCO CAPITAL PARTNERS LLC's CIK is 0001225978

Past Insider Trading and Trends

2008 was SCO CAPITAL PARTNERS LLC's most active year for acquiring shares with 35 total transactions. SCO CAPITAL PARTNERS LLC's most active month to acquire stocks was the month of November. 2008 was SCO CAPITAL PARTNERS LLC's most active year for disposing of shares, totalling 14 transactions. SCO CAPITAL PARTNERS LLC's most active month to dispose stocks was the month of November. 2014 saw SCO CAPITAL PARTNERS LLC paying a total of $108,485,192.00 for 31,250,048 shares, this is the most they've acquired in one year. In 2007 SCO CAPITAL PARTNERS LLC cashed out on 10,325,052 shares for a total of $10,600,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ABEONA THERAPEUTICS INC. (ABEO) Snapshot price: $4.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.72%
-80.00K
$2.01
-$160,888.00
11.08M
Scheduled
May 3
Form 4
-0.71%
-80.00K
$2.23
-$178,624.00
11.16M
Scheduled
Mar 18
Form 4
-1.06%
-120.00K
$2.97
-$356,808.00
11.24M
Scheduled
Feb 16
Form 4
-2.07%
-240.00K
$3.01
-$722,832.00
11.36M
Scheduled
Feb 8
Form 4
-2.68%
-320.00K
$2.06
-$658,516.23
11.6M
Scheduled
Jan 14 - Jan 19
Form 4
-0.02%
-1.99K
$2.00
-$3,981.38
11.92M
Scheduled
Sep 15
Form 4
-0.65%
-78.01K
$2.07
-$161,725.69
11.92M
Scheduled
Sep 10 - Sep 11
Form 4
-0.66%
-80.00K
$2.85
-$228,312.00
12M
Scheduled
Aug 17
Form 4/A
+19,535.85%
13.38M
$4.00
$53,500,096.00
13.44M
Dec 24
Form 4
+19,207.05%
13.38M
$4.00
$53,500,096.00
13.44M
Dec 24
Form 4
—
0
—
—
0
Mar 7
Form 4
—
0
—
—
0
Dec 19
Form 4
—
0
—
—
0
Oct 25
Form 4
+89.82%
1.64M
—
—
3.46M
Feb 26
Form 4/A
∞
901.58K
—
—
901.58K
Jan 4
Form 4
+116.29%
916.17K
—
—
1.7M
Feb 4
Form 4
—
0
—
—
0
Dec 18
Form 4
—
0
—
—
0
Feb 4
Form 4/A
—
0
—
—
0
Nov 10
Form 4
∞
822.14K
—
—
822.14K
Jan 4
Form 4
—
0
—
—
0
Nov 10
Form 4
—
0
—
—
0
Dec 6
Form 4
—
0
—
—
0
Oct 24
No matching records found

ENHANCE BIOTECH INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Somanta Pharmaceuticals Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.25M
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 31
Form 3
—
0
—
—
0
No matching records found

MACROCHEM CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
23.42M
Dec 18
Form 4
—
0
—
—
0
Apr 18 - Jun 12
Form 4
+260.35%
17.88M
—
—
24.74M
Apr 25
Form 4
—
0
—
—
0
Apr 18
Form 4
+664.99%
6.83M
$0.60
$4,099,835.40
7.86M
Oct 10
Form 4
—
0
—
—
0
Mar 5
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Dec 28
Form 3
—
0
—
—
0
No matching records found

BIOENVISION INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.25%
688.33K
$1.50
$1,032,499.50
6.81M
May 1
Form 4
+24.00%
1.23M
$3.38
$4.43
6.35M
Nov 1
No matching records found